How frailty affects the effectiveness of influenza vaccination in older adults
Official title: Frailty and Influenza Vaccination Among Older Adults
Funded at VA Greater Los Angeles Healthcare System · NIH-11044065 · Data updated 2026-11-12
This study is looking at how frailty affects how well the flu vaccine works for older adults, especially veterans living in the community or in care centers, to help improve vaccination strategies for those who are more at risk.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | VA Greater Los Angeles Healthcare System NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project start | January 1, 2024 |
| Project end | June 30, 2029 |
| Funding year | 2025 |
| NIH project number | 5IK2CX002648-02 |
| Project ID | NIH-11044065 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults, particularly Veterans, who may exhibit varying levels of frailty.
✕Less likely to help
Patients who are not older adults or do not have any frailty concerns may not benefit from this research.
What this research studies
This research investigates the relationship between frailty and the effectiveness of influenza vaccination among older adults, particularly focusing on community-dwelling Veterans and those in Community Living Centers. It aims to assess whether frailty, measured using the VA Frailty Index, influences vaccine effectiveness and outcomes after vaccination. By understanding these links, the research seeks to improve vaccination strategies for older adults who are at higher risk of severe outcomes from influenza. The study will utilize electronic assessments and analyze data to draw meaningful conclusions.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies that enhance protection for older adults against influenza and its complications.
How similar studies have gone: Previous research has indicated that frailty can impact vaccine effectiveness, suggesting that this approach may yield valuable insights.
Where this research is happening
-
VA Greater Los Angeles Healthcare System
Los Angeles, United States Active
Researchers
- Principal investigator: Seligman, Benjamin Joseph — VA Greater Los Angeles Healthcare System
- Study coordinator: Seligman, Benjamin Joseph
Related research
Other NIH-funded projects on the same topics.
-
Frailty and Flu Vaccination in Older Adults
This project studies how frailty in older adults affects how well the flu vaccine works and how likely they are to have good outcomes after vaccination.
-
How frailty affects flu vaccination outcomes in older adults
This study is looking at how being frail affects how well the flu vaccine works for older adults aged 65 and up, with the goal of finding ways to better protect those who are more vulnerable.
-
How the immune system responds to flu shots and flu infection
This project looks at how adults' immune systems react after flu shots or when they catch the flu to find why some people get better protection than others.
-
Motivational interviewing to increase COVID-19 and flu vaccination
This project teaches primary care providers conversational skills to help more adults, especially those in vulnerable communities, feel comfortable getting COVID-19 and flu shots.
-
Universal flu vaccine strategy to protect against diverse influenza strains
A research team is testing new vaccine designs aimed at broad protection against many flu strains for people who want lasting immunity.
-
Flu vaccine responses and infection risk in people over 75
This project looks at immune responses to seasonal flu vaccines in adults over 75 to find patterns linked to protection or risk of infection.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.